Internal Medicine, Nephrology · Edison, NJ
NPI
1558304782
Since 2006
Specialty
Internal Medicine, Nephrology
Code 207RN0300X
Group practices
2
Medicare group memberships
Hospitals
7
Hospital affiliations
34-36 Progress St, Suite A-7
Edison, NJ, 08820
Phone (908) 769-1440
Groups this clinician bills Medicare through
Medicare paid, 2024
$876K
10,695 services
Medicare patients, 2024
1,131
Average age 77
Drug cost, 2024
$1.6M
12,198 prescriptions
Company payments, 2025
$1,609
From 22 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Robert Czyzewski was code 99232 (hospital e&m - subsequent), 5,736 times for 676 patients. In total Robert Czyzewski billed 10,695 services in 39 codes, and Medicare paid $876K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-01-14.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 5,736 | 676 | $69.55 | $399K |
| 99308 SNF E&M | Facility | 1,011 | 123 | $64.58 | $65K |
| 99214 Office E&M - Established | Office | 765 | 273 | $105.84 | $81K |
| 99222 Hospital E&M - Initial | Facility | 556 | 432 | $115.11 | $64K |
| 99307 SNF E&M | Facility | 398 | 52 | $32.49 | $13K |
| 90960 ESRD Related Services (not dialysis) | Office | 328 | 45 | $312.26 | $102K |
| 99233 Hospital E&M - Subsequent | Facility | 253 | 75 | $104.31 | $26K |
| 99239 Hospital Discharge Management | Facility | 213 | 170 | $102.40 | $22K |
| 99238 Hospital Discharge Management | Facility | 128 | 104 | $70.99 | $9,086 |
| 99309 SNF E&M | Facility | 97 | 35 | $95.03 | $9,218 |
| 99223 Hospital E&M - Initial | Facility | 88 | 80 | $152.45 | $13K |
| 99306 SNF E&M | Facility | 76 | 71 | $152.98 | $12K |
| 96372 Injection Administration | Office | 62 | 21 | $12.65 | $785 |
| 99213 Office E&M - Established | Office | 54 | 42 | $74.96 | $4,048 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 46 | 46 | $149.94 | $6,897 |
By year: 2022 $744K for 10,032 services; 2023 $786K for 9,962 services; 2024 $876K for 10,695 services.
Lab tests billed to Medicare, 2023
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 104 | 72 | $8.08 | $840 |
Medicare prescription drug claims, 2024
In 2024, the drug Robert Czyzewski prescribed most often to Medicare patients was Amlodipine Besylate, with 521 prescriptions and refills. In total Robert Czyzewski wrote 12,198 Medicare prescriptions that cost $1.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Amlodipine Besylate Generic | 521 | 826 | 122 | $3,063 |
| Atorvastatin Calcium Generic | 519 | 812 | 132 | $5,172 |
| Furosemide Generic | 469 | 664 | 113 | $2,400 |
| Losartan Potassium Generic | 391 | 621 | 93 | $3,784 |
| Farxiga Dapagliflozin Propanediol | 368 | 611 | 95 | $314K |
| Eliquis Apixaban | 364 | 410 | 75 | $159K |
| Levothyroxine Sodium Generic | 303 | 435 | 65 | $3,048 |
| Pantoprazole Sodium Generic | 297 | 415 | 61 | $2,267 |
| Gabapentin Generic | 295 | 386 | 66 | $3,073 |
| Metoprolol Succinate Generic | 256 | 430 | 67 | $3,541 |
| Metoprolol Tartrate Generic | 251 | 350 | 63 | $1,627 |
| Metformin Hcl Generic | 221 | 371 | 50 | $1,780 |
| Alprazolam Generic | 218 | 218 | 46 | $1,458 |
| Omeprazole Generic | 204 | 294 | 34 | $2,095 |
| Mirtazapine Generic | 197 | 207 | 41 | $4,045 |
Brand drugs: 1,935 claims; generic drugs: 10,147 claims; opioid claims: 470.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Robert Czyzewski $1,609 ($1,609 in general payments such as food, travel and fees) from 22 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $319.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 9 | $319 |
| ANI Pharmaceuticals, Inc. ANIP | 10 | $173 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 9 | $160 |
| Travere Therapeutics, Inc. TVTX | 7 | $120 |
| Ardelyx, Inc. ARDX | 7 | $119 |
| Novartis Pharmaceuticals Corporation NVS | 5 | $93.22 |
| Vifor Pharma, Inc. | 6 | $91.36 |
| Corcept Therapeutics CORT | 4 | $64.81 |
| Vivus LLC | 4 | $63.05 |
| Dexcom, Inc. DXCM | 3 | $54.96 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.